Delivery Order SPE2DB22D2009-SPE2DB24FL8QH
Award Date
3/9/24
Potential Completion Date
3/11/24
Potential Value
$6.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,792.23 order is for the supply of MICARDIS HCT 80-12.5 MG TABLET UD 30S, a branded pharmaceutical product, with a completion date of March 5, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 through December 31, 2025,...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution firm AmerisourceBergen Corporation, to provide MICARDIS HCT 40-12.5 MG TABLET UD 30S medication. The $1,637.40 contract has a performance period through January 26, 2024 and does not utilize any set-aside designations. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,037.48 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of MICARDIS HCT 80-25 MG TABLET UD 30S. This delivery order is a part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, valued up to $999,999,999.00 and with a performance period through December 31, 2025. The IDC serves as the primary vehicle for...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide MICARDIS HCT 40-12.5 MG TABLET UD 30S pharmaceutical products. The contract has an ultimate completion date of April 15, 2024 and a ceiling value of $4,151.04. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp by DLA with a potential value of...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, to provide MICARDIS HCT 80-25 mg tablet prescriptions. The contract, valued at $1,294.00, has a performance period through March 5, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, serves as the prime contractor...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide MICARDIS HCT 40-12.5 MG TABLET UD 30S. The contract has a potential value of $2,007.78 and a completion date of February 15, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,556.28 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of MICARDIS HCT 80-25 MG TABLET UD 30S pharmaceuticals. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $6,528.60 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Micardis HCT 40-12.5 mg tablet units. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 to supply pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order valued at $1,989.04 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. This order, which does not have a set-aside designation, is for the supply of MICARDIS HCT 80-25 MG TABLET UD 30S, a brand name pharmaceutical product. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00...
The U.S. Defense Logistics Agency (DLA) awarded a $1,317.97 firm-fixed-price delivery order contract (SPE2DB22D3102|SPE2DB24FL1NM) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of MICARDIS HCT 80-25 MG TABLET UD 30S. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range...